News for 'Clinical Science'

'We are looking at flying an Indian into space'

'We are looking at flying an Indian into space'

Rediff.com8 Dec 2023

'It's vital that over the next 10 years, that India, the US and the Artemis Accords family of nations come together to ensure that we not only return humanity to the moon, but that we build the technology that will allow us stay there permanently.' 'And then go on to Mars.'

7 Cliches Of Movie Criticism & Reporting

7 Cliches Of Movie Criticism & Reporting

Rediff.com19 Jan 2024

This isn't a hatchet job, and my excuse for the exercise is my feeling that when you invert some of the clichés mentioned here, you might just arrive at the portals of genuine movie-making energy, says Sreehari Nair.

Day after US debate, buzz over Vivek Ramaswamy grows as does fundraising

Day after US debate, buzz over Vivek Ramaswamy grows as does fundraising

Rediff.com25 Aug 2023

Indian-American multimillionaire biotech entrepreneur Vivek Ramaswamy's popularity rating and online fundraising have surged, a day after his impressive performance at the first Republican presidential primary debate.

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Rediff.com15 Sep 2020

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.

You'll stop eating sugar after reading this!

You'll stop eating sugar after reading this!

Rediff.com5 Oct 2017

A high sugar diet could increase your risk of heart disease.

Maharashtra, Rajasthan not to allow sale of Ramdev's Coronil

Maharashtra, Rajasthan not to allow sale of Ramdev's Coronil

Rediff.com25 Jun 2020

While Maharashtra Home Minister Anil Deshmukh warned the yoga guru that the state government won't allow the sale of 'spurious' medicines, Rajasthan Health Minister Raghu Sharma also said that the state government will not allow the sale of Patanjali's Ayurvedic formulation.

COVID vaccine likely to be available by first of 2021: Choubey

COVID vaccine likely to be available by first of 2021: Choubey

Rediff.com19 Sep 2020

Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

Rediff.com14 Jun 2021

In the trial, the vaccine will be given by the intramuscular route in two doses on day 0 and day 28.

US can declare 'independence' from China with India's help: Vivek Ramaswamy

US can declare 'independence' from China with India's help: Vivek Ramaswamy

Rediff.com27 Aug 2023

He is currently on a two-day swing to the crucial State of Iowa. On January 15, Iowa would kick off the 2024 Republican presidential primary season.

'Deadline for COVID-19 vaccine unfeasible, unrealistic'

'Deadline for COVID-19 vaccine unfeasible, unrealistic'

Rediff.com6 Jul 2020

'The Indian Academy of Sciences, strongly believes that any hasty solution that may compromise rigorous scientific processes and standards will likely have long-term adverse impacts of unforeseen magnitude on citizens of India'

Ramdev's Patanjali claims to have COVID-19 medicine; Govt frowns

Ramdev's Patanjali claims to have COVID-19 medicine; Govt frowns

Rediff.com23 Jun 2020

While Ramdev claimed that Ayurved-based 'Coronil and Swasari' medicine have shown 100 per cent favourable results during clinical trials on COVID-19 infected patients except those on a life support system, the Ayush Ministry sought from the company detailed report on composition, testing and other data of the drugs.

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Rediff.com25 Aug 2021

If things go according to plan, the vaccine would be available in the market by the end of this year.

China warns of countermeasures for Covid curbs on its travellers abroad

China warns of countermeasures for Covid curbs on its travellers abroad

Rediff.com3 Jan 2023

Foreign ministry spokesperson Mao Ning went on the offensive saying "we do not believe the entry restriction measures some countries have taken against China are science-based".

India is doing fine, unlikely to witness spike in Covid cases: Virologist

India is doing fine, unlikely to witness spike in Covid cases: Virologist

Rediff.com23 Dec 2022

Kang said that "at the moment, India is doing fine" but maintained that surveillance should be ensured to "detect signal of any changes in the behaviour of the virus".

7 Foods Diabetics Should Avoid

7 Foods Diabetics Should Avoid

Rediff.com14 Nov 2022

Starting your day with breakfast cereals or granola bars is something diabetic patients should totally avoid.

'ChatGPT' Vivek Ramaswamy in 2nd spot behind Trump after US debate

'ChatGPT' Vivek Ramaswamy in 2nd spot behind Trump after US debate

Rediff.com24 Aug 2023

Former New Jersey Governor Chris Christie and a Republican presidential aspirant have called his fellow rival Indian-American Vivek Ramaswamy a guy who sounds like ChatGPT and described him as an "amateur" Barack Obama.

Hydroxychloroquine doesn't help treat COVID-19: Report

Hydroxychloroquine doesn't help treat COVID-19: Report

Rediff.com22 Apr 2020

Trump has been aggressively promoting the use of hydroxychloroquine in the treatment of COVID-19 patients.

COVID-19 may cause long-term lung damage: Study

COVID-19 may cause long-term lung damage: Study

Rediff.com27 May 2021

"Many COVID-19 patients are still experiencing breathlessness several months after being discharged from hospital, despite their CT scans indicating that their lungs are functioning normally," said Professor Fergus Gleeson, the study's principal investigator at Oxford.

China succumbs to pressure, shares Covid situation with WHO

China succumbs to pressure, shares Covid situation with WHO

Rediff.com30 Dec 2022

They agreed to continue technical exchanges to help end the epidemic worldwide as soon as possible, it said.

Anti-Covid drug developed by DRDO cleared for emergency use

Anti-Covid drug developed by DRDO cleared for emergency use

Rediff.com8 May 2021

It said clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.

7-year-old Jharkhand girl found with monkeypox-like symptoms, alert issued

7-year-old Jharkhand girl found with monkeypox-like symptoms, alert issued

Rediff.com27 Jul 2022

The Jharkhand government has asked health officials to remain on alert and arrange isolation beds in all district hospitals after a seven-year-old girl was detected with symptoms similar to monkeypox in Garhwa, an official said on Wednesday.

China rolls out first one-jab COVID-19 vaccine: Report

China rolls out first one-jab COVID-19 vaccine: Report

Rediff.com28 Feb 2021

China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the United States drug regulator on Sunday.

Serum gets nod for phase 2, 3 trials of Covid vaccine in India

Serum gets nod for phase 2, 3 trials of Covid vaccine in India

Rediff.com3 Aug 2020

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

India working on Russia's proposal to manufacture Covid vaccine

India working on Russia's proposal to manufacture Covid vaccine

Rediff.com8 Sep 2020

Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert group on COVID-19 vaccine administration, said the government attaches 'great importance to this offer of partnership from a very special friend to this nation'.

The Army Doctor Who Won Hearts In Turkey

The Army Doctor Who Won Hearts In Turkey

Rediff.com8 Mar 2023

Major Beena Tiwari was the only woman in the 99-member medical team at the Indian Army's field hospital in earthquake-hit Turkey.

Indian pharma firms working on new repurposed drug for Covid-19

Indian pharma firms working on new repurposed drug for Covid-19

Rediff.com2 Sep 2020

Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations.

Bharat Biotech finds Covaxin 81% efficient in Phase 3 trials

Bharat Biotech finds Covaxin 81% efficient in Phase 3 trials

Rediff.com4 Mar 2021

Vaccine major Bharat Biotech on Wednesday said its COVID-19 vaccine, Covaxin, has demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials.

Modi's 2-day K'taka visit from Monday, to attend Yoga Day event in Mysore

Modi's 2-day K'taka visit from Monday, to attend Yoga Day event in Mysore

Rediff.com19 Jun 2022

The PMO said mass yoga demonstrations will be organised at 75 iconic locations across the country under the leadership of 75 Union ministers, with Modi attending the exercise at Mysore.

Health ministry okays HCQ for early course of COVID-19

Health ministry okays HCQ for early course of COVID-19

Rediff.com13 Jun 2020

The health ministry on Saturday recommended the use of antiviral drug remdesivir in moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the anti-malarial drug should be used in the early course of the disease and not on critically ill patients.

Scientists win Nobel chemistry for 'genetic scissors'

Scientists win Nobel chemistry for 'genetic scissors'

Rediff.com7 Oct 2020

Charpentier, 51, and Doudna, 56, are just the sixth and seventh women to win the Nobel Prize in chemistry, according to France 24.

Covaxin's 50 pc efficacy adequate for Covid, say experts

Covaxin's 50 pc efficacy adequate for Covid, say experts

Rediff.com26 Nov 2021

The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.

Scientists urge caution over launch of Covid vaccine by Aug 15

Scientists urge caution over launch of Covid vaccine by Aug 15

Rediff.com4 Jul 2020

'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'

4 Habits To Keep Your Heart Healthy

4 Habits To Keep Your Heart Healthy

Rediff.com9 Nov 2022

Food (ahara) and lifestyle (vihara) have a major impact on the health of your heart.

Booster jab should protect current, future Covid strains: Randeep Guleria

Booster jab should protect current, future Covid strains: Randeep Guleria

Rediff.com23 Mar 2023

The renowned pulmonologist, who was part of the national COVID task force, highlighted the need for research on developing vaccines which will cover not only the current circulating strains but also from the emerging variants.

Ayurveda doctor joins race for COVID-19 cure

Ayurveda doctor joins race for COVID-19 cure

Rediff.com8 May 2020

'If the trial succeeds, it will become the success of Ayurveda.' 'If it's a failure, it's my failure alone.'

DRDO's Covid drug: Benefits. Concerns

DRDO's Covid drug: Benefits. Concerns

Rediff.com31 May 2021

Commercial launch and supply to major government and private hospitals is expected in mid-June.

7 Indian pharma players race to develop COVID-19 vaccine

7 Indian pharma players race to develop COVID-19 vaccine

Rediff.com19 Jul 2020

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Rediff.com2 Jul 2021

By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.

Will India's Covaxin be world's first COVID-19 drug?

Will India's Covaxin be world's first COVID-19 drug?

Rediff.com3 Jul 2020

'We need to prove to the world that quality vaccines and R&D are possible in India.'

Russia eyes partnership with India for COVID-19 vaccine

Russia eyes partnership with India for COVID-19 vaccine

Rediff.com20 Aug 2020

'We believe that India is capable of producing the Gamaleya vaccine and it is very important to say that those partnerships to produce the vaccine will enable us to cover the demand that we have'